Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine Praxis
-
Schweiz. Rundsch. Med. Prax. · Mar 1990
[Correction of funnel chest using the Senning-Johanson method].
Between 1962 and 1987 52 patients underwent surgical reconstruction of pectus excavatum at the University Hospital of Zurich using the Senning-Johanson method, first published in 1974. The technique of Senning-Johanson consists of a Y-shaped sternotomy and a transsection of the involved ribs from inside of the thoracic cage, thereby avoiding a dissection of the anterior chest wall. The average age of the 36 men and 16 women was 20 years (range 12-33). ⋯ The vital capacity was preoperatively normal and was not changed by the operation. Thirty-seven patients considered the operative result to be good, in twelve it was satisfactory, and in three bad. The funnel-chest repair using the Senning-Johanson method can be recommended as a successful procedure with relatively few complications for the adult patient.
-
Schweiz. Rundsch. Med. Prax. · Mar 1990
Case Reports[Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
Vysorel/Isorel is an aqueous extract from fresh mistletoe (viscum album). A number of components with different possible effects have been isolated, but exact analyses of the preparation have not been published. One ampoule 'Stärke 60' of 1 ml contains the extract of 60 mg mistletoe. ⋯ None of the 33 case histories suggests that Vysorel/Isorel is effective in the treatment of malignant diseases. Vysorel/Isorel is not registered in Switzerland at the IKS. It has been permitted in Austria since 1983 and in Germany since 1986.
-
Schweiz. Rundsch. Med. Prax. · Mar 1990
Clinical Trial[Helixor--mistletoe preparation for cancer therapy. Documentation No. 19].
Helixor is an aqueous cold extract from fresh mistletoe, obtained from fir, pine and apple trees. A number of components with different possible effects were isolated: lectins, viscotoxins, alkaloids, etc. "Oncological therapy" and "stimulation of the bone marrow" are given as the main fields of indication. Pregnancy, hyperthyroidism and intolerances are given as contraindications. ⋯ Specific effects of Helixor on the immune system and its actual bearing on the tumour process have so far not been unequivocally elucidated. The three clinical-historical comparative studies contain methodological errors. They do not provide evidence of the clinical efficacy against tumours.(ABSTRACT TRUNCATED AT 250 WORDS)